Drug reference

carbachol

Carbamoyl ester, muscarinic agonist · Muscarinic Agonist

Carbamoyl ester, muscarinic agonistMuscarinic Agonist

CDSCO approved

EXCRETION

—

not curated

INTERACTIONS

—

none in our sources

PREGNANCY

—

not curated

Mechanism

Unsubstituted carbamoyl ester, almost completely resistant to hydrolysis by cholinesterases, leading to longer duration of action. Retains substantial nicotinic activity.

Indications

Treatment of glaucoma (topical)Induction of miosis during surgery (topical)miosis in surgeryglaucoma

Side effects

Common

corneal edemamiosisinduced myopiadecreased visionbrow acheretinal detachment

Drug interactions

Anticholinesterases

Mild

Textbook

Additive cholinergic effects.

Source: KDT 7e · p104

Related guidelines

Preoperative cardiac evaluation for non-cardiac surgery

AHA · Cardiology · 2025

Glaucoma

AIOS · Ophthalmology · 2022

Induction of labour

FOGSI · Obstetrics & Gynaecology · 2019

Diabetes management during Ramadan

ADA · Endocrinology · 2025

Plaque psoriasis

IADVL · Dermatology · 2022

Other Carbamoyl ester, muscarinic agonist drugs

bethanechol

0 brands

Ask House about carbachol

Continue into a citation-backed clinical answer with the drug context already attached.

Open in workspace Ask House about this drug

Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team